Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

Date: 
15 Nov 2017
Source: 
The BMJ
Audience: 
Patients and public
Type of resource: 
Research

To determine the availability of data on overall survival and quality of life benefits of cancer drugs approved in Europe.

 

Click here to read the Research article in full